News

Testing drug sensitivity on tumor tissue at physiological oxygen levels could act as a new screening method for drug efficacy.

A computational biology researcher has reported a cross-reaction between Bacillus Calmette-Guérin and SARS-CoV-2 that might help explain what could be driving immunity brought on by the BCG vaccination.

The World Health Organization (WHO) has strongly recommended the drug baricitinib for patients with severe or critical COVID-19 in combination with corticosteroids. In the same guideline update, it also makes a conditional recommendation for the use of the monoclonal antibody sotrovimab in patients with non-severe disease, but only in those at the highest risk of hospitalization.

Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster their defenses against skin cancer.

New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV.

New research indicates kidney damage could be a potential long-term effect of medications that combat high blood pressure.

A research group has proposed a new strategy for preventing complications associated with sepsis. The researchers believe it to be possible by inhibiting the action of a pore-forming protein called gasdermin D, using a drug already approved to treat alcohol dependence.

Two new studies have identified a previously unrecognized pathway of cell death — named lysoptosis — and demonstrate how it could lead to new therapies for cervical cancer.

Researchers have discovered that a previously little-known protein is necessary for acute myeloid leukemia cell survival.

New research has assessed levels of COVID-19 antibodies before, after five weeks and after six months of nursing home residents receiving two doses of the Pfizer vaccine.